Skip NavigationSkip to Content

Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids

  1. Author:
    Frias, Maria A.
    Mukhopadhyay,Suman
    Lehman, Elyssa
    Walasek, Aleksandra
    Utter, Matthew
    Menon, Deepak
    Foster, David A.
  2. Author Address

    CUNY Hunter Coll, Dept Biol Sci, 413 East 69th St, New York, NY 10021 USA.Weill Cornell Med, Clin & Translat Sci Ctr, Clin & Translat Masters Program, New York, NY 10065 USA.Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA.Frederick Natl Lab Canc Res, 8560 Progress Dr, Frederick, MA 21701 USA.Pfizer Worldwide Res & Dev, 401 N Middletown Rd, Pearl River, NY 10965 USA.Suny Downstate Med Ctr, 450 Clarkson Ave, Brooklyn, NY 11203 USA.Univ Maryland, 650 Baltimore St, Baltimore, MD 21201 USA.Weill Cornell Med, 1300 York Ave, New York, NY 10065 USA.
    1. Year: 2020
    2. Date: JAN 3
  1. Journal: JOURNAL OF BIOLOGICAL CHEMISTRY
  2. AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC,
    1. 295
    2. 1
    3. Pages: 263-274
  3. Type of Article: Article
  4. ISSN: 0021-9258
  1. Abstract:

    Mammalian target of rapamycin complex 1 (mTORC1) promotes cell growth and proliferation in response to nutrients and growth factors. Amino acids induce lysosomal translocation of mTORC1 via the Rag GTPases. Growth factors activate Ras homolog enriched in brain (Rheb), which in turn activates mTORC1 at the lysosome. Amino acids and growth factors also induce the phospholipase D (PLD)?phosphatidic acid (PA) pathway, required for mTORC1 signaling through mechanisms that are not fully understood. Here, using human and murine cell lines, along with immunofluorescence, confocal microscopy, endocytosis, PLD activity, and cell viability assays, we show that exogenously supplied PA vesicles deliver mTORC1 to the lysosome in the absence of amino acids, Rag GTPases, growth factors, and Rheb. Of note, pharmacological or genetic inhibition of endogenous PLD prevented mTORC1 lysosomal translocation. We observed that precancerous cells with constitutive Rheb activation through loss of tuberous sclerosis complex subunit 2 (TSC2) exploit the PLD?PA pathway and thereby sustain mTORC1 activation at the lysosome in the absence of amino acids. Our findings indicate that sequential inputs from amino acids and growth factors trigger PA production required for mTORC1 translocation and activation at the lysosome.

    See More

External Sources

  1. DOI: 10.1074/jbc.RA119.010892
  2. PMID: 31767684
  3. PMCID: PMC6952608
  4. WOS: 000505982700021

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel